Cristina Falcao
Orphan Diseases - Living with Ataxia’s Nightmare in the Land of Innovation
November 30 by Cristina FalcãoThe patient is the most important stakeholder in healthcare. Every day patients are questioning their treatment options and making product choices through their own research. With orphan d...
Waltzing Away in Pharma Wonderland with Polichinelle
September 20 by Cristina FalcãoPharma Fallacies ? Mais c'est le secret de Polichinelle ! Bien entendu, les apparences sont sauves…. “Puff,” the mighty, magic outsourcing dragon is the “jack-o...
Where Have All The Experts Gone? Long Time Passing...When Will They Ever Learn?
July 18 by Cristina Falcão“Think Globally, Act Locally”! What better description of Big Pharma? With scattered facilities, operations, alliances and partnerships,throughout the world, globalisation is no news in...
Pharmaceutical Outsourcing, Where Do You Draw the Line?
May 20 by Cristina Falcão
The real issue in pharma is budget and structural change. There are no magic methods to overcome what Richard Nelson called "the simple economics of basic scientific research—patents or no patents, ca...
Social Media and Pharma Industry, a Paradoxical Oxymoron?
April 19 by Cristina FalcãoThe world’s most highly regulated industry seems doomed to “forward retreat” tiptoeing into Social media. Why? The reason lies on social media’s gist - user generated content...
Pharmaceutical Revenues under Threat - The Impact of Expected Major Changes and New Regulations
March 25 by Cristina FalcãoBased on new regulations, increased costs of R & D, the expiration of dozens of patents, the lack of future ‘cash cows’, the new transparency rules and the value-based pricing, pharmaceutical comp...
